RecruitingPhase 2NCT06676774

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

Studying Arginine vasopressin deficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Basel, Switzerland
Principal Investigator
Mirjam Christ-Crain, Prof. Dr.
University Hospital, Basel, Switzerland
Intervention
Oxytocin nasal spray(drug)
Enrollment
42 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06676774 on ClinicalTrials.gov

Other trials for Arginine vasopressin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Arginine vasopressin deficiency

← Back to all trials